![]() |
市場調查報告書
商品編碼
1635542
神經調節設備市場:規模、佔有率、監管、報銷、程序及 2036 年各細分市場預測Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
神經調節設備是一種透過調節神經系統活動來治療各種神經和精神疾病的醫療設備。神經調節劑透過向神經系統的目標區域傳遞電或磁刺激來發揮作用。神經調節裝置為治療神經和精神疾病的傳統方法(如藥物和手術)提供了一種替代方法。此類別包括深部腦部刺激器 (DBS)、胃電刺激器 (GES)、導線、薦神經刺激器 (SNS)、脊髓刺激器 (SCS)、週邊神經刺激器 (PNS) 和迷走神經刺激器 (VNS)。
由於高齡化社會中神經系統疾病的發生率很高,龐大的老年人口基數是神經調節市場的主要驅動力。
本報告對全球神經調節設備市場進行了深入分析,包括競爭格局、 SWOT 分析、 2036 年市場預測、區域和國家趨勢。
Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.
Neuromodulation devices are medical devices that are used to treat various neurological and psychiatric disorders by modulating the activity of the nervous system. Neuromodulation Devices work by delivering electrical or magnetic stimulation to targeted areas of the nervous system. Neuromodulation devices offer an alternative to traditional treatments for neurological and psychiatric disorders, such as medications and surgery. Deep brain stimulators (DBS), gastric electric stimulators (GES), leads, sacral nerve stimulators (SNS), spinal cord stimulators (SCS), peripheral nerve stimulators (PNS) and vagus nerve stimulators (VNS) are the segments covered under this category.
Due to the large prevalence of neurological conditions impacting the aging population, this huge geriatric population base is a large driver of the neuromodulation market.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Neuromodulation Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, LivaNova Plc, Nevro Corp, AirLife, Beijing Pins Medical Co Ltd, Curonix LLC, Bioness Inc, Avanos Medical Inc, B. Braun Melsungen AG, Axonics Inc, NeuroPace Inc, Xavant Technology (Pty) Ltd, Enterra Medical Inc and Others
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -